Access Bio Inc (950130) — Cash Flow-to-Debt Ratio
Access Bio Inc (950130) has a Cash Flow-to-Debt Ratio of -0.14x as of June 2025, meaning its operating cash flow of ₩-9.16 Billion could theoretically repay 0% of its total liabilities (₩67.08 Billion) in one year. See cash generation quality of Access Bio Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Access Bio Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Access Bio Inc across 13 annual periods. Also explore Access Bio Inc (950130) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Access Bio Inc (2012–2024)
Year-by-year debt coverage analysis for Access Bio Inc. For market capitalisation and broader financial context, see market value of Access Bio Inc.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.22x | ₩13.54 Million | ₩61.70 Million | ▲ +28427.1% |
| 2023 | 0.00x | ₩-80.57 Million | ₩104.00 Billion | ▼ -100.1% |
| 2022 | 1.38x | ₩291.33 Million | ₩210.97 Million | ▲ +31.3% |
| 2021 | 1.05x | ₩137.90 Million | ₩131.10 Million | ▼ -99.8% |
| 2020 | 462.09x | ₩36.72 Billion | ₩79.47 Million | ▲ +4368.9% |
| 2019 | -10.82x | ₩-422.24 Million | ₩39.01 Million | ▲ +90.3% |
| 2018 | -111.49x | ₩-5.73 Billion | ₩51.40 Million | ▲ +5.8% |
| 2017 | -118.30x | ₩-5.45 Billion | ₩46.03 Million | ▼ -244657.5% |
| 2016 | 0.05x | ₩2.11 Million | ₩43.68 Million | ▼ -92.8% |
| 2015 | 0.68x | ₩2.87 Billion | ₩4.24 Billion | ▲ +365.5% |
| 2014 | -0.25x | ₩-2.63 Billion | ₩10.35 Billion | ▼ -244.2% |
| 2013 | 0.18x | ₩1.59 Billion | ₩8.99 Billion | ▼ -29.4% |
| 2012 | 0.25x | ₩1.85 Billion | ₩7.38 Billion | — |